Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
8-20-2019 1:00 PM

Role of the fibronectin-binding, collagen-binding, T-antigen region
during nasopharyngeal infection by Streptococcus pyogenes
Akshay Sule, The University of Western Ontario
Supervisor: McCormick, John K., The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Master of Science degree in
Microbiology and Immunology
© Akshay Sule 2019

Follow this and additional works at: https://ir.lib.uwo.ca/etd

Recommended Citation
Sule, Akshay, "Role of the fibronectin-binding, collagen-binding, T-antigen region during nasopharyngeal
infection by Streptococcus pyogenes" (2019). Electronic Thesis and Dissertation Repository. 6542.
https://ir.lib.uwo.ca/etd/6542

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

Abstract
Streptococcus pyogenes is a human-specific pathogen that uses a variety of adhesion
molecules in order to initiate pharyngeal infection and maintain colonization. One genomic
locus that is believed to contribute to adherence is the fibronectin-binding, collagenbinding, T-antigen (FCT) region, primarily due to the inclusion of genes that encode for a
pilus (tee18.1), collagen-binding protein (cpa), and fibronectin-binding protein (prtF2).
The precise role of these genes and the FCT region as a whole, however, have yet to be
elucidated within the context of pharyngeal infection. In this study, we utilize the M18
serotype S. pyogenes strain MGAS8232 to demonstrate that the presence of the FCT region
is critical in binding collagen type IV and fibronectin, and is additionally required for
invasion into human pharyngeal cells, despite not impacting adherence to these cells.
Furthermore, using a murine nasopharyngeal infection model, we determine that only cpa
is expressed in vivo, and that removal of the FCT region does not impede the bacteria’s
ability to establish infection. Overall, this study demonstrates that the FCT region is not
involved during acute nasopharyngeal infection by S. pyogenes MGAS8232 but may
contribute to the pathogenic life cycle through other mechanisms.

Keywords
Streptococcus pyogenes, pilus, collagen-binding protein, fibronectin-binding protein, acute
nasopharyngeal infection, transgenic mouse model
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Lay Summary
Streptococcus pyogenes is a human-specific bacterium that can cause a multitude of
diseases with outcomes that range from mild to fatal. Streptococcal pharyngitis, or more
commonly known as ‘strep throat’, is one of these diseases and affects more than 600
million people annually. Although this disease can be self-limiting or treated with
antibiotics, the persistence or recurrence of pharyngeal infection can result in more harmful
complications, such as rheumatic heart disease, which can be fatal in severe cases. As such,
it is critical to understand the initial infectious state of S. pyogenes. A crucial step during
its pharyngeal infection is the adhesion to host tissue, which occurs through a variety of
molecules that are often attached to the bacteria’s surface. One particular genomic locus
implicated in adhesion is the fibronectin-binding, collagen-binding, T-antigen (FCT)
region, which notably encodes a pilus structure (tee18.1), a collagen-binding protein (cpa),
and a fibronectin-binding protein (prtF2). In this study we remove this region from the
bacteria’s genome and assess the adherence capabilities of this mutant to several
components found at the site of infection, including collagen type IV, fibronectin, and
human pharyngeal cells and demonstrated that the FCT region is required to bind collagen
type IV and fibronectin, but not the pharyngeal cells. Interestingly, we discovered that the
ability to invade pharyngeal cells, which may lead to more detrimental diseases, is entirely
reliant on the FCT region. In addition, we quantify the expression of tee18.1, cpa, and
prtF2 in mice that have been infected with S. pyogenes and determined that only cpa was
expressed. Furthermore, using the same mouse nasopharyngeal infection model, we
demonstrated that removal of the FCT region does not impede the bacteria’s ability to
establish infection. This study demonstrates that the FCT region is not involved during
acute nasopharyngeal infection by S. pyogenes but may contribute to the pathogenic life
cycle through other mechanisms. Overall, comprehensively evaluating the life cycle of S.
pyogenes can provide insight on how to combat this globally-prevalent pathogen.
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Chapter 1: Introduction
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1.1. Streptococcus pyogenes
Streptococcus pyogenes, sometimes referred to as the Group A Streptococcus, is a Grampositive, aerotolerant anaerobe with human-specific tropism. This bacterium typically
grows in chains of varying lengths and exhibits the characteristic β-hemolysis of red blood
cells. Classification of β-hemolytic streptococci is based on the expression of cell wall
polysaccharides and subsequent categorization into Lancefield antigen groups A, B, C, D,
etc., wherein S. pyogenes is the only species to be classified as a Group A Streptococcus
(1). Isolates and strains of this species are further classified through examination of the
variable (~20) Lancefield T-antigen, as well as the variable (>230) M protein (2). The S.
pyogenes genome consists of a ~1.8 Mbp circular chromosome with a G+C content of
~38.5%. Many genes encoded within S. pyogenes, most notably virulence factors, display
great variability between strains, which can be attributed to the inclusion of exogenous
genetic elements such as phage, and phage-like insertions, as well as genetic mobility
through horizontal gene transfer (3–5). Although S. pyogenes can colonize the skin and
mucosal surfaces asymptomatically, it can also act as an opportunistic pathogen and cause
a multitude of diseases with clinical manifestations ranging from mild to fatal (6, 7). Some
of these diseases may be self-limiting such as pharyngitis or impetigo, while others can be
more severe such as necrotising fasciitis or toxic shock syndrome. Additionally, S.
pyogenes has been linked to various post-infection sequelae such as glomerulonephritis, or
acute rheumatic fever (ARF) and the subsequent development of rheumatic heart disease
(RHD) (8). Accordingly, S. pyogenes represents a significant affliction on human health.

1.2. Streptococcal infection and the global burden of disease
S. pyogenes, and the various diseases it can cause, are a major source of worldwide
morbidity and mortality. Population studies have estimated that the annual incidence of
acute pharyngitis and the superficial skin infection impetigo are at least 616 million and
140 million cases, respectively (9, 10). Symptoms of streptococcal pharyngitis include
fever, enlarged lymph nodes, and inflammation of the pharynx with exudations on the
tonsil (11, 12). Although the majority of S. pyogenes infections can be self-limiting or
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treated efficiently with β-lactam antibiotics, the persistence of the bacteria, or invasion past
the epithelial barrier, can result in more severe diseases (10, 12).

Invasive streptococcal disease is characterized by the bacteria entering a normally-sterile
site, including the bloodstream, fascia, muscle, or lungs. Infection in these areas can then
lead to potentially fatal diseases, including bacteremia, streptococcal toxic shock syndrome
(STSS), or necrotising fasciitis. Unfortunately, epidemiological data suggests that the
prevalence of invasive streptococcal disease is increasing (9, 10). STSS, which is the most
dangerous form of invasive streptococcal disease, is believed to be mediated by S.
pyogenes-produced toxins (13). Early symptoms of STSS are often non-specific but the
progression of this disease is associated with early muscle pain or pharyngitis, followed by
the onset of fever and hypotension, which may ultimately lead to multiple organ failure,
and in ~40% of cases, death (14–16). Treatment of STSS primarily includes supportive
therapy, antibiotic treatment with a focus on penicillin and clindamycin, and may include
the use of polyclonal intravenous immunoglobulins (IVIG). In recent years, however, an
increasing number of studies find that despite the reduction in organ failure and other
clinical manifestations, the use of IVIG results in patient survival rates that are statistically
no different than the control groups (17–19). Necrotizing fasciitis, otherwise known as
“flesh-eating disease,” is characterized by necrosis of the subcutaneous tissue and fascia,
and presents with symptoms including severe pain, fever, and necrotic tissue with edema
(20, 21). The rapid spread of necrotising fasciitis makes it crucial to remove the necrotic
tissue and treat the affected area(s) with an antibiotic regimen similar to STSS (20).

Infection with S. pyogenes can also induce post-infection sequalae such as ARF or poststreptococcal glomerulonephritis. ARF is a delayed consequence that may occur due to the
persistence or recurrence of untreated S. pyogenes pharyngeal infection, and can result in
damage to the joints, brain, and heart (12, 22). The most substantial manifestation of ARF
is repeated immune-mediated damage to the heart valves, which can progress into RHD
(23). Globally, there have been estimated to be at least 18.1 million cases of severe S.
pyogenes infection annually, with 517,000 of these cases resulting in death; the greatest
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contributor to mortality is RHD, which results in 345,000 deaths annually, with an
additional 116,000 deaths being caused by RHD-mediated complications (9, 10).

The precise incidence of diseases caused by S. pyogenes, however, is likely
underrepresented given that the bacteria affects low-resource settings significantly more
than high-income areas. Aside from the biological and geographical factors influencing
prevalence, the burden of S. pyogenes can be greatly accredited to socioeconomic factors
such as poor sanitation standards and lack of access to healthcare. Coupled with the absence
of efficient data managing systems and epidemiological models, these circumstances
obscure the actual statistical prevalence, incidence, and mortality of S. pyogenes infection
in areas where the impact of disease is greatest. The global burden of this organism has
caused the World Health Organization to categorize S. pyogenes as the ninth leading cause
of human mortality with respect to infectious diseases, thus highlighting the importance of
understanding the pathogenesis of this organism (10, 24).

1.3. Asymptomatic Carriage
The asymptomatic carriage of S. pyogenes is characterized by the presence of bacteria
without any signs or symptoms indicative of infection. Indeed, the predominant form of
interaction between S. pyogenes and humans is asymptomatic carriage, in which
persistence in the pharynx is considered the primary reservoir for a variety of S. pyogenes
strains (25). In addition, S. pyogenes is able to asymptomatically colonize the skin, vagina,
and rectum, but does so to a lesser degree (26). Concerning asymptomatic carriage,
detection of S. pyogenes is typically a two-step process that involves a posterior pharynx
swab as well as serological testing (27). One meta-analysis found that 37% of children with
sore throat presented signs of pharyngitis, and 12% of the children studied were deemed
asymptomatic carriers (28). Additionally, it has been documented that approximately 25%
of household cohabitants of children with streptococcal pharyngitis were positive for S.
pyogenes while remaining asymptomatic, therefore suggesting that carriage is linked to
living situations within a closed environment (29). Nevertheless, asymptomatic carriers of
S. pyogenes do not seem to be capable of efficiently transmitting the bacteria. This may be
due to several reasons, such as lack of respiratory secretions and symptoms that would
4

typically help the spread of bacteria, as well as the reduced density of S. pyogenes in the
pharynx of carriers compared to symptomatic individuals (30, 31). Although it is predicted
that host factors and bacterial determinants that assist immune evasion may prompt the
development of asymptomatic carriage, the majority of studies detailing this highly
common state are epidemiological in nature (27). As such, the exact molecular mechanisms
that contribute to asymptomatic carriage of S. pyogenes remains unclear.

1.4. Streptococcus pyogenes secreted virulence factors
S. pyogenes employs a multitude of secreted virulence factors to mediate the start of
infection as well as subsequent colonization of the host. This vast array of factors includes:
DNAses, cytolytic toxins, proteases, bacteriocins, complement inhibitors, as well as
mitogenic toxins known as superantigens. Although there are many more secreted
virulence factors that contribute to the pathogenesis of S. pyogenes within its infectious
niche, superantigens are of particular relevance to this project (32, 33).

1.4.1. Superantigens
Superantigens refer to a family of mitogenic toxins produced by a limited number of
microorganisms. Most notably, these compounds are produced by S. pyogenes and
Staphylococcus aureus, but are also expressed by other bacteria such as Yersinia
pseudotuberculosis and Mycoplasma arthritidis, as well as viruses including the mouse
mammary tumour virus (34–37). These unique toxins are characterized by their ability to
bridge the connection between the human leukocyte antigen (HLA) major
histocompatibility complex (MHC) class II molecules on antigen-presenting cells and the
variable-β (Vβ) chain of T cell receptors on T cells; peculiarly, superantigens can undergo
this binding without a specific singular peptide (38). Depending on the particular sequence
and architecture of each superantigen, it preferentially interacts with a subset of Vβ-specific
T cells and certain MHC class II molecule haplotypes (39, 40). Because superantigens are
able to circumvent the peptide-specific nature of immunity, they are able to activate up to
20% of a host’s T cell population, which is in stark contrast to the 10-3–10-4% of naïve T
cells that are activated during classical antigen-specific immunity (37, 40).
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Historically, streptococcal superantigens have been implicated in numerous diseases
including scarlet fever and STSS, yet their evolutionary function has yet to be solidified.
Previous studies from our laboratory have postulated that superantigens are crucial for the
initiation of infection by S. pyogenes (41, 42). In order to substantiate this concept, we
developed a novel murine nasopharyngeal infection model that bypasses the humanspecific tropism of S. pyogenes by utilizing mice that express HLA MHC class II molecules
(alleles DR4/DQ8) (41, 43). Using this model, we verified that the streptococcal pyrogenic
exotoxin A (SpeA) was necessary for the mice to consistently develop a robust acute
infection (41). Moreover, we demonstrated that vaccination with a toxoid version of SpeA
resulted in antibody-mediated protection thereby preventing S. pyogenes infection upon
bacterial challenge (43). It therefore stands that the relationship SpeA has with the host
extends beyond causing severe diseases, and instead may primarily function to initiate
acute infection and persist in the nasopharynx. Additionally, because S. pyogenes encodes
numerous superantigens, this role in pathogenesis may be preserved through redundancy.

1.5. Streptococcus pyogenes surface adherence molecules
In addition to the arsenal of secreted factors, S. pyogenes also utilizes a variety of surfacelinked adhesion molecules in order to avoid bacterial clearance from host-derived
mechanical, cellular, and humoral defenses. Some of these predicted factors include
lipoteichoic acid (LTA), M protein, the hyaluronic acid capsule, pili, collagen-binding
proteins, and fibronectin-binding proteins (FBPs) (44–47). Adhesion in S. pyogenes has
been hypothesized to be a two-step process, in which LTA initially mediates weak
hydrophobic interactions with host cells proceeded by high affinity interactions between
specific S. pyogenes adhesion molecules and their cognate receptors (48). Interestingly, the
expression of these adhesion factors differs dramatically between S. pyogenes strains, and
is thought to be a significant contributor to stain-specific tissue tropism (25, 49).

1.5.1. M protein
The M protein, encoded by the emm gene, is a major surface component of S. pyogenes,
and remains one of the most studied virulence factors from this bacterium. This protein is
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attached to the bacterial cell wall through a conserved LPXTG motif at its C-terminus,
while its N-terminus encodes a hypervariable region exposed to the extracellular
environment (2, 50). The genetic variability in its N-terminus has resulted in more than 230
emm types, which serve as the basis for S. pyogenes serotype (2, 51, 52).

This multifunctional protein is primarily known for its function in antiphagocytic immune
evasion. It accomplishes this by attaching to various host proteins to prevent the activation
and deposition of complement factors on the bacterial surface (53–55). The molecular
diversity within its hypervariable N-terminus also presents the opportunity to bind a
plethora of human host cells and receptors (44, 54). Studies have demonstrated that M types
may play a role in adhesion to various tissue types. For example M1, M5, and M6 serotypes
have been shown to adhere HEp-2 cells and the pharyngeal cell line Detroit-562, but, along
with M24 and M3, are not responsible for mediating adhesion to buccal epithelial cells
(56–58). Moreover, M proteins from various serotypes were found to bind the keratinocyte
membrane cofactor protein 46 (CD46); the M6, M12, and M18 proteins, however,
displayed weak or no binding to CD46, indicating that this protein is not a universal target
of the M protein (59, 60). Therefore, the diverse binding capabilities of different M proteins
constitute the potential for a range of serotype-specific host-pathogen interactions.

The M protein has also been potentially implicated in tissue tropism and disease
manifestations (61, 62). M proteins are grouped together based on their architecture, as
well as their inclusion or exclusion of certain domains. emm groups A-C are
overwhelmingly obtained from pharyngeal isolates, whereas group D are strongly
associated with skin infections. Dissimilarly, strains that are included within group E are
considered generalists, and have been obtained from both pharyngeal and skin isolates (45,
62–64).

1.5.2. Hyaluronic acid capsule
The majority of S. pyogenes strains produce a high molecular weight polysaccharide
capsule composed of hyaluronic acid. Notably, hyaluronic acid is a major component of
the human extracellular matrix (ECM), thereby making the capsule immunogenically inert
7

(7, 65). Although the precise function of the capsule is still debated, multiple studies have
implicated a role in adhesion through its interaction with the host ligand CD44, which is
involved in adherence to pharyngeal tissue by host cells (66–68).

Of importance, the regulation of the hyaluronic acid capsule seems to be heavily dependant
on the nature of infection. For instance, it has been demonstrated in baboons that 1 hour
post-inoculation in the pharynx, capsule gene expression is upregulated, suggesting a role
during the early stages of infection (69). Moreover, the hyperencapsulated M18 serotype
has been shown to persist longer in the nasopharynx of mice compared to a mutant strain
that had reduced capsular expression (70). Contrarily, the hyperencapsulation of the
virulent M1T1 strain is hypothesized to diminish adhesion to human pharyngeal cells due
to its long hyaluronic acid chains physically obstructing other adhesion molecules and their
access to host ligands. (71). By producing a molecule identical to a compound found in its
host, S. pyogenes is able to utilise a possible infection or colonization factor while
simultaneously evading the host immune response.

1.5.3. The fibronectin-binding, collagen-binding, T-antigen
region
In addition to standalone components that mediate adhesion, S. pyogenes also encodes a
variable genomic locus, known as the Fibronectin-binding, Collagen-binding, T-antigen
(FCT) region. Due to the gene composition of this locus, it is hypothesized to play an
important role in the adhesion of S. pyogenes to ECM proteins and various epithelial cells.
To date, there have been 9 distinct variants of the FCT region identified amongst the many
S. pyogenes strains, with further strain-specific sequence variation also reported within the
encoded genes (49, 72). Although the origin of this ~9‒16 kb locus is presently unknown,
it is believed to have evolved its genetic organization and allelic variability through
intergenomic homologous recombination events, as well as potential transposase activity
(72–74). Flanked by two highly conserved genes, the general constituents of this locus are
detailed in Table 1.
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Table 1. Genes encoded within the different FCT region variants
Gene

Description

Presence of gene in
FCT region variants a
All FCT variants

rofA or nra

Standalone regulator

prtF1

Fibronectin-binding protein F1

FCT-1, FCT-4, FCT-5, FCT-7,
FCT-8, FCT-9

cpa/fctX

Ancillary pilus protein 1/
collagen-binding protein

FCT-1, FCT-2, FCT-3, FCT-4,
FCT-5, FCT-6, FCT-8

lepA/sipA1/sipA2

Putative signal peptidase

FCT-2, FCT-3, FCT-4, FCT-7,
FCT-8

tee/fctA

Major pilus subunit/T-antigen

All FCT variants

srtB/srtC2

Locus-specific sortase

All FCT variants

fctB

Ancillary pilus protein 2/
pilus anchoring subunit

FCT-2, FCT-3, FCT-4, FCT-5,
FCT-6, FCT-7, FCT-8, FCT-9

msmR

Standalone regulator; only
present in strains with prtF2

FCT-3, FCT-4, FCT-7, FCT-8

prtF2

Fibronectin-binding protein F2

FCT-3, FCT-4, FCT-5, FCT-7,
FCT-8

inv/rev

Putative transposable element

FCT-1, FCT-2, FCT-5, FCT-9

a

The presence of certain constituents within the 9 distinct FCT variants was organized in this
table based on information from various sources (49, 75–79).

9

1.5.3.1. Pili
The most notable component of the FCT region is the pilus, which is a polymer composed
of a major pilus subunit, as well as one or two ancillary proteins. Specifically, ancillary
protein 1 is a collagen-binding protein that is usually attached to the pilus tip, and ancillary
protein 2 anchors the pilus to the cell wall (80, 81). Interestingly, in some cases, the major
pilus subunits are the T-antigens used in serological classification implying that distinct
FCT regions encode antigenically distinct pili (47, 82, 83). These subunits are comprised
of two immunoglobulin-like domains, which attach to adjacent subunits via a covalent
isopeptide bond (84). After numerous rounds of head-to-tail polymerization, the ~2nm
wide and >1µm long pilus is anchored to the cell wall via the highly conserved ancillary
protein 2 (47, 84). Biochemical and structural analysis of the pilus led to speculation that
disruption of the isopeptide bond would substantially compromise the integrity of the pilus.
Indeed, the loss of one isopeptide bond causes a weakened ability to withstand stressors
such as thermal stability or trypsin-resistance, and this pattern is even more prominent in
mutants devoid of both isopeptide bonds (85). Other studies have since supported the
stability-conferring properties of the isopeptide bonds and illustrated that its rigid and
inextensible nature allows the pilus to withstand mechanical pressures such as coughing
(85, 86). This works through the constant breaking of the isopeptide bonds due to
mechanical pressure followed immediately by the automatic restoration of the bonds such
that the majority of the energy subjected to the pilus is lost as heat, rather than through a
more permanent loss of integrity (86–88). The pilus has also been shown to adhere to
human tonsil epithelia, which is a major initial site for S. pyogenes upper respiratory tract
infection (12, 89). Moreover, deletion of the major pilus subunit results in reduced adhesion
to pharyngeal cell lines compared to the wildtype strain, with the greatest disparity
occurring at earlier time points (<30 minutes), suggesting that the pilus is transiently
regulated (90). Despite these findings, there is no evidence directly validating the major
pilus subunit as the agent responsible for adhesion; instead, studies predict that ancillary
protein 1 interacts with host ligands to mediate adhesion (91–93).
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1.5.3.2. Collagen-binding protein
Some strains harbour the pilus ancillary protein 1, otherwise referred to as the collagenbinding protein, Cpa. Most commonly, studies have determined a pilus model in which
Cpa is located at the tip of the pilus, thus naming it ancillary protein 1. Depending on the
strain, however, S. pyogenes can encode cpa with the classical LPXTG motif that anchors
Cpa to the cell wall, or an alternative (Q/E/V)(V/P)PTG motif that can be attached to the
major pilus subunit, ancillary protein 2, or anchored to the cell wall through a locus-specific
sortase encoded within the FCT region (47, 94–96). This structural inconsistency can be
visualized using immunogold labelling, which has depicted Cpa at the top of the pilus (e.g.
M1, M3, and M6), as well as at the base of the pilus (e.g. M49) (47, 97, 98). Despite the
sequence variability between cpa of different strains, a common feature is the ability to
bind collagen type I and type IV, leading to its hypothesized role in adherence during
colonization, which is presently unconfirmed (76, 99). It has also been shown to contain a
thioester bond, which may mediate an interaction with cognate receptors on host cells
(100). In addition, deletion of cpa results in an attenuated ability for S. pyogenes to adhere
to human lung and pharyngeal cell lines (89, 91). Clinical evidence from Cpa-seropositive
patients indicated an association with people afflicted with arthritis and osteomyelitis,
suggesting the possibility that Cpa interacts with collagen type I found in the bones and
synovia (99). Thus, the combination of evidence suggests that Cpa can be utilized by S.
pyogenes in a variety of ways in order to establish itself in the host, and that for some
strains it may be vital in the formation of tissue-specific infections.

1.5.3.3. Fibronectin-binding proteins
The FCT region can also encode genes for one or two FBPs: prtF1/sfbI and/or
prtF2/pfbp/fbaB. These proteins, although structurally distinct, are functionally related in
that they facilitate adhesion to fibronectin and are involved with S. pyogenes internalization
via the α5β1 integrin (101–103). Architecturally, these FBPs consist of one to five tandem
repeat domains that are directly proportional to the strength of fibronectin binding, and in
some cases, internalization efficiency (104–106). Moreover some strains of S.pyogenes
share sequence homology between these FCT region-encoded FBPs and other FBPs, such
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as fbaA or sof, which are located near the emm genomic cluster (2, 107). The regulation of
these FBPs can be remarkably precise, as it has been demonstrated that for some strains
the FBPs are upregulated in oxygen-rich conditions and downregulated when carbon
dioxide availability increases (106, 108). This may suggest a transient role for FBPs during
initial colonization of the skin and respiratory tract, and that they become less involved
during late, deep tissue stages of infection at which point the expression of other virulence
factors involved in maintaining the infection are prioritized (44). Explorations of the M3
and M18 serotypes have demonstrated that PrtF2 is partially responsible for binding human
pharyngeal cells and subsequently mediating bacterial internalization into these host cells.
Cumulatively, these data substantiate the idea that the FCT region-encoded FBPs may be
critical during initial adhesion to the host, as well as in progressing to an infectious state
(109, 110).

1.5.3.4. The relationship between the fibronectin-binding,
collagen-binding, T-antigen region and tissue tropism
The type of FCT region (i.e. FCT-1 through FCT-9) has been suggested to play a role in
tissue tropism. For example, epidemiological data has shown that approximately 80% of
skin isolates (emm pattern D) encode the FCT-4 region, whereas less than 15% of throat
isolates (emm pattern A‒C) encode the FCT-4 region (25). Experimental analysis,
however, does not appear to demonstrate major differences in vitro for adherence of
different throat and skin isolates to a series of cell lines (111). Further complexity regarding
S. pyogenes tissue tropism is introduced when considering that FCT region genes are
subject to global regulators that affect their transcriptional expression during different
pathogenic scenarios (107).

1.6. Regulation in Streptococcus pyogenes
Having evolved alongside humans throughout history, S. pyogenes has adapted incredibly
well to our various tissues in order to cause infection and subsequently colonize our bodies.
In particular, S. pyogenes has demonstrated an aptitude for immune avoidance, niche
colonization, and in general, mitigating pathology in order to foster an ideal
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microenvironment that is conducive to persistence within its host. A key factor in this
remarkable feat is the regulation of virulence. In a multifaceted approach, regulation in S.
pyogenes involves a circuit of coordinated gene regulators that respond to molecular cues
from the host and environment. The S. pyogenes transcriptome is controlled by at least 13
two-component systems and 30 known stand-alone regulators (>100 including putative
gene regulators) (12). As such, for the purpose of this thesis, we will focus on some of the
key regulators and how they influence survivability and pathogenesis.

1.6.1. CovRS
A prominent two-component system in S. pyogenes is the CovRS system, which primarily
responds to environmental stress signals, such as antimicrobial peptides, increased
temperature, iron starvation, or excess Mg2+ (112–114). Similar to other two-component
systems, the process of regulation begins with a membrane-bound histidine kinase sensor,
CovS, which then autophosphorylates and subsequently transfers the phosphoryl group to
the response regulator, CovR (115, 116). This results in the dimerization of CovR, which
is then able to bind DNA and modulate gene expression (117). The CovRS system is known
to regulate the transcription of approximately 15% of the S. pyogenes genome, with an
emphasis on virulence factors. Most commonly, CovRS acts to repress the expression of
genes, including DNAses, cytolysins, and the hyaluronic acid capsule (118). Distinctively,
the CovRS system appears to activate the transcription of the SpeB protease (119). It has
also been documented that a non-functioning CovRS system leads to a hypervirulent
phenotype, such as that which occurs in the globally-circulated M1T1 clone (120). Genetic
analysis of the M1T1 clone unearthed a frameshift mutation in covS, inhibiting action of
the CovRS system (121, 122). This hypervirulent phenotype is characterized by increased
expression of virulence factors, such as the hyaluronic acid capsule and SpeA, and reduced
expression of SpeB (12, 70, 123). The outcome of this mutation imparts CovRS mutants,
such as the M1T1 strain, with a proclivity for systemic infection while being resistant to
phagocytosis (121).
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1.6.2. Mga
Stand-alone regulators account for a considerable portion of S. pyogenes regulation, and
one of the best-studied is Mga. The chief function of Mga is to control the expression of
several genes, particularly the M protein, genes involved in metabolism, and immune
evasion genes; however, it has also been shown to regulate the primary regulator of the
FCT region, rofA/nra (124, 125). All strains of S. pyogenes encode for one of the two mga
alleles, which are suspected to contribute to tissue tropism [mga-1 (throat isolates) and
mga-2 (skin isolates/generalists)] (124, 126). Regardless of the mga variant, this regulator
is consistently expressed during the exponential growth phase that most frequently occurs
during early stages of infection (126, 127). Therefore, it is likely that Mga transcriptionally
upregulates genes involved with the initial acute stage of infection and adhesion factors
that prevent early mechanical clearance of S. pyogenes.

1.6.3. RofA/Nra
All strains of S. pyogenes encode RofA and/or Nra, and may additionally contain RALP3
and/or RivR, which are all members of the RofA-like protein family (119, 128). Typically,
these regulators are associated with the transition between the exponential phase and early
stationary phase of growth (129). RofA and Nra, which notably share 63% sequence
homology, are both encoded within the FCT region and attune the transcription of the genes
encoded therein (129). Specifically, RofA directly upregulates transcription of the pilus,
prtF1, as well as cpa and itself concurrently through an intergenic binding sequence (130).
Peculiarly, Nra, which is found in a more limited range of S. pyogenes serotypes, is
repeatedly described as a negative repressor of the aforementioned FCT region genes as
well as prtF2. A possible explanation for this functional dichotomy may relate to the sites
of infection for rofA+ and nra+ strains, which preferentially infect and colonize the throat
and skin, respectively. Thus, these strains may differ in their requirements for spatial or
temporal regulation in order to combat site-specific challenges (49, 126, 131).

Although Nra is generally reported as a negative repressor of FCT region genes, its activity
appears to be strain-specific as it has also been described as a positive regulator for cpa in
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an M53 skin infection strain (132). Distinctively, some strains appear to have forfeited their
use of Nra while maintaining their pathogenicity. For instance, MGAS315 (isolated from
a patient with STSS) naturally produces negligible levels of pili, partially attributed to a
non-synonymous mutation in nra that results in attenuated regulatory activities (133, 134).
Furthermore, introduction of an overexpressed Nra plasmid demonstrates that genes within
M3 isolates are categorically upregulated by Nra (133). Relatedly, M18 strains appear to
harbour an early stop codon in nra, effectively truncating it during translation, and although
this mutation has not been studied, it is tempting to speculate that expression of Nra in M18
isolates would also upregulate numerous genes (135). This research suggests that for strains
in which Nra acts as a positive regulator, basally high expression levels may be
evolutionarily disadvantageous to S. pyogenes (133).

Given that there are numerous RofA and Nra binding sites present throughout the genome,
these regulators also appear to have a function with regards to global virulence (125, 129,
131). This is further supported by studies that have demonstrated RofA and Nra activity
leads to transcriptional downregulation of many genes related to virulence, including the
hyaluronic acid capsule, SpeA, the SpeB protease, the cytolytic toxin streptolysin S, as well
as Mga (125, 129, 131, 136). The act of downregulating Mga, which typically upregulates
both RofA and Nra, further highlights the dynamic interplay between regulatory bodies in
S. pyogenes and how they communicate to coordinate infection and sustain colonization.

1.6.4. MsmR
The FCT region can also encode the stand-alone regulator msmR, but its presence in this
locus only occurs in strains that also encode prtF2 (77, 137). Principally, MsmR is involved
in the upregulation of FBPs, regardless of their location within the genome (137).
Interestingly, MsmR has been shown to simultaneously upregulate cpa and nra, which
emphasizes the significance of expressing antithetical regulators to fine-tune virulence and
colonization. Transcriptional regulation by MsmR also appears to function antipodally to
Nra, regardless of the strain; that is, when Nra acts as a repressor, MsmR generally acts as
an activator, and vice versa (119, 132). Collectively, the interconnected network of

15

regulators in S. pyogenes exemplifies the necessity to precisely modulate virulence factors
during each strain’s unique life cycle.

1.7. Rationale and hypothesis
S. pyogenes resides within the throats of several hundred million people, yet many of the
bacterial factors that help initiate and maintain pathogenicity remains unelucidated within
the context of colonization and an acute pharyngeal infection. The FCT region is of
particular interest since studies detailing its role during infection are less intensively
studied compared to other surface-linked virulence factors, such as the M protein or
hyaluronic acid capsule. Additionally, this study provides an exploratory opportunity to
characterize the genes found within the FCT region of a strain that was isolated from an
outbreak of ARF, MGAS8232 (135).

During the early stages of pharyngeal infection by S. pyogenes, adherence factors aid in
the onset of infection by adhering to host tissue to prevent the rapid and initial clearance
of bacteria (44, 45). Three components often implicated in this mechanism are the pilus,
its commonly associated collagen-binding protein, and FBPs, all of which are encoded
within the FCT region of MGAS8232 (Figure 1). I hypothesized that these factors would
be crucial for S. pyogenes to initiate infection in the nasopharynx of mice. Using a genetic
deletion of the FCT region (from the start of cpa until the end of prtF2), I predict that in
vitro binding of S. pyogenes to relevant human tissue will be reduced. Moreover, using our
transgenic murine nasopharyngeal infection model, for which MGAS8232 has previously
been verified to consistently infect, I speculate that the deletion of the FCT region will
inhibit the ability for S. pyogenes to establish itself in the nasal turbinates.
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Figure 1. The FCT-3 region, and the adjacent upstream and downstream genes,
found in S. pyogenes MGAS8232.
The genetic organization of the FCT-3 region. The small arrows delineate the flanking
boundaries of the portion of the FCT region that was chromosomally deleted in the ΔFCT
mutant.
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Chapter 2: Methods
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2.1. Ethics Statement
All animal experiments were completed under Animal Use Protocol (AUP) Number 2017024 in compliance with the Canadian Council on Animal Care Guide to the Care and Use
of Experimental Animals, and was approved by the Animal Use Subcommittee at Western
University (London, ON, Canada) (Appendix I).

2.2. Bacteria
A complete list of the bacterial strains used in this study can be found in Table 2.

2.2.1. Escherichia coli
E. coli were grown in Luria-Bertani (LB) broth (Thermo Fisher Scientific; Waltham, MA,
USA) aerobically with shaking at 37°C. During molecular cloning, E. coli were grown on
brain heart infusion (BHI) broth (BD Biosciences; Franklin Lakes, NJ, USA) with 1.5%
(w/v) agar (Thermo Fisher Scientific) and 150µg mL-1 erythromycin (Sigma-Aldrich
Canada; Oakville, ON, Canada) when required. Frozen stock cultures were stored at -80°C
in LB broth with 20% (v/v) glycerol.

2.2.2. Streptococcus pyogenes
S. pyogenes were grown in Todd Hewitt broth (BD Biosciences) supplemented with 1%
(w/v) Bacto yeast extract (BD Biosciences) (THY) statically at 37°C. During molecular
cloning, THY media was supplemented with 1.5% (w/v) agar and/or 1µg mL-1
erythromycin. Frozen stocks were stored at -80°C in THY broth with 20% (v/v) glycerol.

2.2.3. Streptococcus pyogenes growth curves
S. pyogenes MGAS8232 (wildtype and ΔFCT) were grown from frozen -80°C stocks and
subcultured at 1:100 for 2 days until day 3, on which 100mL bottles of pre-warmed THY
media were inoculated with 6mL from the overnight culture and incubated at 37°C until
early exponential phase. Optical densities (OD) were measured at regular intervals using a
spectrophotometer (DU 530 Life Science UV/Vis Spectrophotometer, Beckman Coulter
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Table 2. Bacterial strains used in this study
Strain
Description
Escherichia coli
XL1-Blue
Molecular cloning strain
Streptococcus pyogenes
MGAS8232
M18 serotype isolated from a patient
during an acute rheumatic fever
outbreak (GenBank accession:
AE009949.1)
MGAS8232 ΔFCT
FCT region deletion mutant in the strain
MGAS8232
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Source
Stratagene
(135)

This study

Canada LP; Mississauga, ON, Canada). Bacterial cultures were then adjusted to an OD600
of 0.02 before being loaded into sterile 96-well plates. Bacteria were grown with periodic
shaking and OD600 measurements were obtained every 10 minutes for 20 hours using the
Synergy HTX Multi-Mode Microplate Reader (BioTek; Winooski, VT, USA).

2.3. Molecular cloning
This section details the methodologies that were used to generate the ΔFCT mutant.

2.3.1. DNA visualization
DNA samples were loaded into wells of a 1% (w/v) agarose gel in TAE (40 mM Trisacetate, 1 mM EDTA) buffer along with a 1-kb Plus DNA ladder (Invitrogen; Carlsbad,
CA, USA). Gels were run at 100V for 1 hour using the PowerPac 200 Electrophoresis
Power Supply and Chamber (Bio-Rad Laboratories; Hercules, CA, USA) and subsequently
stained in 0.05% (v/v) ethidium bromide in TAE buffer for 20 minutes. DNA gels were
then visualized using ultraviolet light on a gel doc (Bio-Rad Laboratories).

2.3.2. Sequencing of DNA
DNA samples (with the inclusion of primers when necessary) were sequenced by the
Sequencing Facility at the John P. Robarts Research Institute in London, ON, Canada.
Primers used for sequencing can be found in Table 3.

2.3.3. Plasmid isolation from Escherichia coli
Plasmid DNA was isolated from overnight cultures of E. coli using the instructions as
outlined by the QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany). A complete list of
plasmids can be found in Table 4.

2.3.4. Genomic DNA isolation from Streptococcus pyogenes
To isolate total genomic DNA from S. pyogenes, 2mL of an overnight culture was
centrifuged at 15,000 × g for 2 minutes. Bacteria were washed with 1mL 0.2mM sodium
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Table 3. Primers used in this study
Primer
Primer sequence (5’ → 3’)a
Primers used to generate the ΔFCT construct
FCT up KpnI for
CGC GGTACC GAGGAATGCTAACTGCAAAT
FCT up PstI rev
CGC CTGCAG CCTCTTTTGCAATATATCCTC
FCT down PstI for
CGC CTGCAG TCATCATGTTAAGATAAGCTG
FCT down BamHI rev
CGC GGATCC TCTTCACTTCACTACTAGCAG
Primers used for sequencing and deletion confirmation
M13 for
GTAAAACGACGGCCAGT
M13 rev
CAGGAAACAGCTATGAC
FCT integration for
CAGCAAGTTTCAATATGCTG
FCT integration rev
AACACAGACATAGTAACGAC
Internal primers used during qRT-PCR
gyrA RT for
GGTTCGTATGGCTCAGTGGT
gyrA RT rev
TTCTCTTTCGCTTCCATCGT
Int cpa for
GCAGAACCATACTCTGTAACAG
Int cpa rev
CATTAAAGTCTGGATCAATCG
Int tee18.1 for
CAGGAGTGATTGATGGTTTAG
Int tee18.1 rev
AACATCAACTGTCCATTGTTG
Int prtF2 for
GGAATGGCTTACATTTATTCTG
Int prtF2 rev
CACCTGAAACAATATCTGGTG
a

Restriction endonuclease cut sites are underlined

23

Table 4. Plasmids used in this study
Plasmid
pG+host5
pG+host5::ΔFCT

Description
E. coli → Gram-positive shuttle vector;
temperature-sensitive, erythromycin resistant
FCT region deletion construct chromosomally
inserted into S. pyogenes MGAS8232
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Source
(138)
This study

acetate then centrifuged again as described. Cells were then lysed with 500µL of a 50mM
EDTA solution with 0.2% (v/v) sodium dodecyl sulphate (SDS) and 0.02µg RNase and
were incubated for 1 hour at 70°C. Following, 50µL of 5M potassium acetate was then
added for 1 hour at -20°C before being centrifuged as described for 10 minutes. The
supernatant was then transferred to a tube with 1mL ice-cold 95% ethanol and left for 1
hour at -20°C. The suspension was centrifuged as described for 10 minutes and the pellet
was washed in 1mL ice-cold 70% ethanol. The solution was then centrifuged again, and
the supernatant was discarded. The DNA pellet was then air-dried and resuspended in
100µL sterile water from the MilliQ purification filtration system (EMD Millipore;
Darmstadt, Germany) before being stored at -20°C.

2.3.5. Polymerase chain reaction
All primers used in this study were obtained from Sigma-Aldrich (Table 3). For a 100µL
polymerase chain reaction (PCR), the mixture consisted of 5× high-fidelity buffer (Thermo
Fisher Scientific), 0.7µL of the high-fidelity DNA polymerase Phusion (Thermo Fisher
Scientific), 3mM deoxyribonucleotide triphosphate (dNTP) (Roche; Basel, Switzerland),
2mM magnesium chloride (Thermo Fisher Scientific), 1µM of each primer (forward and
reverse), and 2µL of DNA. All reactions were performed in an MJ Mini or MJ Research
PTC-200 Thermal Cycler (Bio-Rad Laboratories) using the DNA amplification parameters
as follows: 98°C for 5 minutes for initial denaturation of DNA; 98°C for 30 seconds, 30
seconds at the appropriate melting temperature, 72°C for extension (time: 30 seconds per
1 kb), repeated for 35 cycles; a final extension step at 72°C for 7 minutes before an
indefinite 4°C step before sample removal.

2.3.6. Restriction digests and ligations
DNA restriction endonuclease digests were performed as per the manufacturer’s
instructions (New England BioLabs; Ipswich, MA, USA) before purification using the
QIAquick PCR Purification Kit (Qiagen).
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Purified endonuclease-digested DNA was ligated into the appropriate vector (10 vector:1
insert) using = T4 DNA Ligase (New England BioLabs) and incubated at 16°C for 1 hour.

2.3.7. Generation of competent Escherichia coli cells
To prepare competent rubidium chloride cells, an overnight culture of E. coli was
subcultured into 100mL PSI broth [2% (w/v) Bacto tryptone (BD Biosciences), 0.5% (w/v)
Bacto yeast extract, 0.5% (w/v) magnesium sulphate, pH = 7.6] at a 1:100 dilution and
grown at 37°C with shaking to an OD600 of 0.5. The bacteria were placed on ice for 15
minutes and then centrifuged at 5,000 × g for 5 minutes at 4°C. The pellet was resuspended
in 40mL TfbI buffer [15% (v/v) glycerol, 100 mM rubidium chloride, 30 mM potassium
acetate, 10 mM calcium chloride, 50 mM manganese chloride, pH = 5.8] and incubated on
ice for 15 minutes. Bacteria were centrifuged as stated above and the resulting pellet was
resuspended in 4mL TfbII buffer [15% (v/v) glycerol, 75 mM calcium chloride, 10 mM 3(N-morpholino) propanesulfonic acid, 10 mM rubidium chloride, pH = 6.5] and stored in
200µL aliquots at -80°C.

2.3.8. Transformation of competent Escherichia coli cells
To start, 10µL of plasmid DNA from ligation reactions were added to thawed rubidium
chloride competent E. coli cells and incubated for 30 minutes on ice. Bacteria were then
placed in a 42°C water bath for 45 seconds followed by incubation on ice for 2 minutes.
Afterwards, 900µL of LB broth was added to the cells and incubated for 1 hour at 37°C
with shaking, and then 150µL of the bacteria were spread over BHI agar supplemented
with 150µg mL-1 erythromycin and incubated overnight at 37°C.

2.3.9. Generation of competent Streptococcus pyogenes cells
To prepare competent S. pyogenes cells, an overnight culture was subcultured at a 1:50
dilution into 100mL of THY broth containing 0.6% glycine for 2 hours at 37°C. Following,
5mg of hyaluronidase (Sigma-Aldrich) was then added and the culture was grown to an
OD600 of 0.3. Bacteria were centrifuged at 6,000 × g for 5 minutes and the pellet was
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washed once with 40mL of 15% (v/v) glycerol. The cells were then resuspended in 4mL
of 15% (v/v) glycerol and stored in 200µL aliquots at -80°C.

2.3.10. Electroporation of competent Streptococcus pyogenes
cells
Plasmid DNA (~2µg) were mixed with thawed competent S. pyogenes cells and then
transferred to a 2mm electroporation cuvette. The cells were pulsed exponentially at 2500V
and 600Ω using a GenePulser (Bio-Rad Laboratories). Bacteria were then added to 10mL
of THY and incubated for 3 hours at 37°C before centrifugation at 6,000 × g for 5 minutes.
The cells were then resuspended in 1mL of THY broth and plated on THY agar
(supplemented with 1µg mL-1 erythromycin if necessary) and incubated at 37°C overnight.

2.3.11. Generation of Streptococcus pyogenes deletion mutant
The temperature-sensitive, erythromycin-selection-marked plasmid pG+host5 was used to
delete the FCT region from MGAS8232 via double homologous recombination events
(135, 138) (Table 3).

Two ~1,000bp segments directly upstream and downstream of the cpa and prtF2 genes,
respectively, were amplified from wildtype MGAS8232 genomic DNA, digested using
restriction endonucleases, and subsequently ligated into an accordingly-digested pG+host5
vector (Figure 2A). The generated deletion construct was then transformed into competent
E. coli XL1-Blue.

The deletion construct isolated from E. coli XL1 Blue was then electroporated into S.
pyogenes wildtype MGAS8232 and grown on THY agar supplemented with 1µg mL-1
erythromycin at 30°C overnight; colonies were subsequently picked and grown in THY
liquid media with erythromycin and incubated at 40°C for up to three days. The pG+host5
plasmid is unable to replicate at this temperature, thus, erythromycin-resistance is
indicative of chromosomal integration (Figure 2B). Clones that had the deletion construct
successfully integrated (as verified by PCR) were subcultured 1:100 in THY liquid media

27

Figure 2: Deletion of the FCT-3 region from S. pyogenes MGAS8232.
To genetically remove the FCT region, (A) adjacent segments upstream (US) and
downstream (DS) were amplified by PCR, digested with restriction endonucleases, and
ligated into the temperature-sensitive, erythromycin resistance (ermR)-marked pG+host5
vector. (B) The knockout vector was then electroporated into S. pyogenes to remove the
FCT region from the host chromosome during homologous recombination events that are
contingent on the temperature-sensitive origin of replication (TS Ori) of the pG+host5
vector.
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without erythromycin at 30°C in order to resolve the plasmid (and the FCT region) from
the chromosome. Bacterial cultures were patched onto THY agar with and without 1µg
mL-1 erythromycin, wherein erythromycin-sensitive colonies had been cured of the
pG+host5 plasmid (Figure 2B). These clones were then verified by DNA sequencing and
PCR to confirm the successful deletion of the ΔFCT mutant.

2.4. Protein visualization
Protein samples were visualized using sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) and by Western blot.

2.4.1. Sodium dodecyl sulphate polyacrylamide gel
electrophoresis
Proteins were mixed with Laemmli buffer [125 mM Tris pH 6.8, 50% glycerol, 4% SDS,
5% β-mercaptoethanol, and 0.1% (w/v) bromophenol blue] and boiled for 5 minutes.
Samples (20µL) were then run using SDS-PAGE on 12% (v/v) acrylamide gels in
electrophoresis buffer [25 mM Tris, 250 mM glycine, 0.1% (w/v) SDS] for 30 minutes at
85V then for 1 hour and 30 minutes at 150V. The gels were then stained with coomassie
[0.1% (w/v) coomassie brilliant blue R-250 (Bio-Rad Laboratories), 45% (v/v) methanol,
and 10% (v/v) acetic acid], and destained for visualization [10% (v/v) acetic acid, and 45%
(v/v) methanol].

2.4.2. Western blot
To detect the superantigen SpeA in the wildtype and ΔFCT strains, samples run through
SDS-PAGE were transferred onto polyvinylidene difluoride (PVDF) membranes
(Amersham Hybond, GE Healthcare; Pittsburgh, PA, USA). This was accomplished by
assembling the PVDF membrane and SDS-PAGE gel in a mini trans-blot cell (Bio-Rad
Laboratories) and run for 1 hour at 100V in Western transfer buffer [48 mM Tris base, 39
mM glycine, 0.037% (w/v) SDS, and 20% (v/v) methanol]. The PVDF membrane was then
blocked using 5% (w/v) skim milk in tris buffered saline (TBS). Subsequently, the
membrane was incubated at 4°C overnight with a polyclonal rabbit α-SpeA primary
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antibody [(41), produced by ProSci; Poway, CA, USA] at a 1:1,000 dilution in TBS with
1% (w/v) skim milk. The membrane was then washed in TBS with 0.1% (v/v) tween-20
(Amresco, VWR International; Solon, OH, USA) (TBS-T) 3 times for 5 minutes per wash.
The membrane was then incubated in darkness at room temperature for 1 hour with a goat
α-rabbit IgG conjugated to IRDye800 secondary antibody (Rockland; Limerick, PA, USA)
diluted 1:10,000 in TBS with 1% (w/v) skim milk. The membrane was subsequently
washed 5 times with TBS-T, as described and then visualized using the LI-COR Odyssey
Imaging System (LI-COR Biosciences; Lincoln, NE, USA).

2.5. Cell Surface Extract
To obtain cell wall fractions, wildtype and ΔFCT S. pyogenes were grown from frozen
stocks into 10mL of THY and incubated overnight at 37°C before subculturing 1:100 into
100mL bottles of pre-warmed THY and grown until an OD600 of 0.2‒0.4. The bacteria were
then adjusted to an OD600 = 0.25 and centrifuged at 10,000 × g for 10 minutes. The pelleted
cells were then washed once in PBS and centrifuged again. The cells were then resuspended
in 1mL of cold protoplasting buffer [40% sucrose, 100mM KPO4 (pH = 6.2), 10mM
MgCl2, Complete EDTA-free protease inhibitors (Roche), 2mg ml-1 lysozyme (SigmaAldrich), and 400U mutanolysin (Sigma-Aldrich)] and incubated at 37°C for 3 hours with
constant but gentle movement. The bacteria were then centrifuged at 15,000 × g for 15
minutes at 4°C and the supernatants (cell wall proteins) were collected and stored at -20°C.

2.6. Trichloroacetic acid precipitation
To obtain secreted proteins, wildtype and ΔFCT S. pyogenes were grown from frozen
stocks into THY media and incubated overnight at 37°C before subculturing 1:100 into
100mL bottles of pre-warmed THY and grown for 13 hours. The bacteria were centrifuged
at 10,000 × g for 15 minutes at 4°C and the supernatant was subsequently drawn off and
incubated with 50% trichloroacetic acid (TCA) (Sigma-Aldrich) for 30 minutes. The
supernatant-TCA precipitations were then centrifuged as described above and the pellets
were then washed with ice-cold acetone (Thermo Fisher Scientific) and centrifuged again
as described and the supernatant was removed. The proteins were then resuspended in 1mL
of 8M urea (BioShop Canada Inc; Burlington, ON, Canada) and stored at -20°C.
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2.7. Extracellular matrix binding assay
Wildtype S. pyogenes and the ΔFCT mutant were grown from frozen stocks into 10mL of
THY media, followed by two days of subculturing. At this time, Corning Costar 9018 highbinding 96-well plates (Corning; Kennebuck, ME, USA) were coated with 1µg of collagen
type IV (Sigma-Aldrich) or fibronectin (Calbiochem, EMD Millipore Corporation;
Temecula, CA, USA) dissolved in carbonate-bicarbonate buffer (0.2M sodium carbonate
anhydrous, 0.2M sodium bicarbonate, pH = 9.6) overnight at 4°C. The day after, 6mL of
the overnight S. pyogenes cultures were inoculated into separate 100mL bottles of prewarmed THY and grown until mid exponential phase after which their OD600 values were
corrected to 0.25 before centrifuging the appropriate volume of bacteria at 15,000 × g and
resuspending the pellet in phosphate buffered saline (PBS). While the bacteria were
growing, the plates were washed three times using PBS with 0.05% (v/v) tween-20 and
blocked for 2 hours with 5% (w/v) skim milk at room temperature before being washed
three times as described. Afterwards, 100µL of bacteria (~1 × 107 CFUs) were added in
triplicate to wells and incubated for 2.5 hours at 37°C. Plates were washed three times as
described and fixed with 10% neutral buffered formalin (VWR International; Randor, PA,
USA) for 40 minutes before washing three times again as described. Plates were then
incubated with 50µL of 0.5% (w/v) crystal violet (Sigma-Aldrich) in 80% (v/v) sterile
MilliQ water and 20% (v/v) methanol for 5 minutes at room temperature before being
washed five times. Stain was solubilized in 5% (v/v) acetic acid with mild agitation for 10
minutes. Colorimetric analysis was measured at OD590 using the Synergy HTX MultiMode Microplate Reader (BioTek).

2.8. Human cell culturing
The pharyngeal cell line Detroit-562 (obtained from Dr. Joe Mymryk, Western University)
was grown in sterile 75cm2 tissue culture (TC)-treated flasks (Falcon, Corning; Corning,
NY, USA) in 14mL of minimum essential medium (MEM) (Gibco, Life Technologies;
Grand Island, NY, USA) supplemented with 10% (v/v) heat-inactivated fetal bovine serum
(Sigma-Aldrich), 100 µg mL-1 streptomycin (Life Technologies), and 100 U mL-1
penicillin (Life Technologies) at 37°C in 5% CO2 and washed 2 times every other day with
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PBS (for ~6 days) to remove cellular debris. To split, flasks with cells at ~75% confluence
were dissociated from the flask using 0.25% trypsin-EDTA (Gibco, Life Technologies).

2.8.1. Pharyngeal cell line adhesion assay
Detroit-562 cells were grown to confluence on 12 well TC-treated plates (Falcon, Corning)
and then incubated for 2 hours in serum-free MEM. Three wells were dissociated using
0.25% trypsin and counted using a haemocytometer (Hausser Scientific; Horsham, PA,
USA) to obtain a representative average for the number of Detroit-562 cells per well, which
was used to determine the number of bacterial CFUs to use during the assay [multiplicity
of infection (MOI) = 100]. During this time, 6mL of an overnight culture S. pyogenes that
was previously grown and subcultured for two consecutive days was inoculated into
100mL bottles of pre-warmed THY and grown until mid-exponential phase. The
appropriate volume of S. pyogenes was centrifuged at 15,000 × g and the pellet was
resuspended in serum-, and antibiotic-free MEM and inoculated with the Detroit-562
monolayer for 2.5 hours at 37°C in 5% CO2. Each well was washed 3 times using PBS to
remove non-adherent bacterial cells and the remainder was mechanically lysed in PBS with
0.01% (v/v) Triton X-100 (VWR International) to detach the cells from the plate. The
suspension was then serially diluted (neat → 10-6) and plated on trypticase soy agar (TSA)
supplemented with 5% sheep’s blood (BD Biosciences) for bacterial enumeration the next
day.

2.8.2. Pharyngeal cell line invasion assay
The invasion assay, which is a modification of the classical gentamycin protection assay,
follows the procedure as outlined in section 2.8.1 with an additional step. Briefly, after S.
pyogenes were incubated with the confluent monolayer of Detroit-562 cells for 2.5 hours,
the wells were washed twice with PBS and incubated in MEM supplemented with 100µg
mL-1 gentamycin (Sigma-Aldrich) for an additional 1.5 hours at 37°C in 5% CO2 to kill
extracellular bacteria. As described above, the cells were then detached from the plates in
PBS with 0.01% (v/v) Triton X-100, serially diluted, and plated for bacterial enumeration
the next day.
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2.9. Mice
Transgenic C57BL/6 mice expressing the MHC class II molecules HLA-DR4/DQ8 or
HLA-DQ8 alone were donated from the Kotb laboratory and were since housed and bred
in the West Valley Barrier Facility at Western University (41, 139). S. pyogenes inoculum
preparation and mouse infection were performed as previously described (140).

2.9.1. Murine nasopharyngeal infection
A timeline of the infection model can be found in Figure 3A; to begin, mice were given
water supplemented with 2mg mL-1 neomycin sulphate (VWR International) prior to and
throughout the course of infection in order to inhibit their endogenous nasal microbiota.
Wildtype S. pyogenes and the ΔFCT mutant were grown from freezer stocks in THY and
subcultured 1:100 for two days. On the third day, 6mL of the overnight cultures were then
inoculated into separate pre-warmed bottles of THY and grown to an OD600 of 0.2‒0.4 and
the appropriate volume was resuspended in Hank’s Balanced Saline Solution (HBSS) (Life
Technologies). Mice were anesthetized with isoflurane (USP, Baxter International;
Deerfield, IL, USA) and intranasally inoculated with ~5 × 107 bacterial CFUs per nostril.
Twenty-four or 48 hours post-inoculation, mice were sacrificed and their complete nasal
turbinates (cNTs) were harvested (Figure 3A, Figure 3B). Subsequently, the cNTs were
homogenized in HBSS and a portion of the homogenate was serially diluted (neat → 10-7)
and then plated on TSA supplemented with 5% sheep’s blood for bacterial enumeration
the following day. The remainder of the homogenate was stabilized in RNAprotect Cell
Reagent (Qiagen) for 5 minutes at room temperate, centrifuged at 15,000 × g for 10 minutes
to discard the supernatant, and stored at -80°C until future use.

2.9.2. RNA isolation
S. pyogenes were grown in vitro to an OD600 of 0.2 (early exponential phase) or 0.8 (late
exponential phase) before being incubated with 1mL of RNAprotect Cell Reagent for 5
minutes at room temperature, centrifuged at 15,000 × g for 10 minutes to discard the
supernatant, and stored at -80°C until future use.
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Figure 3. Mouse infection timeline
(A) Two days prior to infection, mice were given 2mg mL-1 neomycin water. They were
then inoculated nasally with the wildtype or ∆FCT strain of S. pyogenes MGAS8232 and
sacrificed 24 or 48 hours later. (B) Their complete nasal turbinates (pink) were then
harvested and processed RNA extraction and/or bacterial enumeration.
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RNA-protected bacterial pellets or murine cNT homogenates were resuspended in 500µL
of Tris-EDTA + glucose (2mM EDTA, 10mM Tris, 25% glucose) buffer with 100µg of
lysozyme and 50 U of mutanolysin followed by incubation for 1 hour at 37°C. The cells
were then centrifuged at 20,000 × g and the pellet was resuspended in 500µL of
streptococcal lysis buffer (50mM EDTA, 0.2% SDS) with 100µg of proteinase K and
incubated for 2 hours at 65°C. RNA was then extracted and purified using the RNeasy Kit
(Qiagen) as per the manufacturer’s instructions.

2.10. Quantitative real-time polymerase chain reaction
Gene-specific primers were designed for cpa, tee18.1, and prtF2 with amplicon lengths of
~200bp and amplified from wildtype MGAS8232 genomic DNA to generate standards for
each gene (Table 3). RNA isolated from murine tissue or in vitro S. pyogenes cultures were
used to generate cDNA using random primers (Invitrogen) and SuperScript II Reverse
Transcriptase (RT) (Invitrogen). The genomic DNA and cDNA were then quantified using
a NanoDrop One/OneC Microvolume UV-Vis Spectrophotometer (Thermo Fisher
Scientific). The concentration was adjusted to 5ng µL-1 and eight 10-fold serial dilutions
were prepared in purified MilliQ water. The quantitative reverse transcriptase (qRT)-PCR
reactions were performed with SensiFAST SYBR Green No-ROX Kit (Bioline, Meridian
Bioscience Inc; London, ON, Canada) as per the manufacturer’s instructions using the
previously-designed gene-specific primers. All reactions were performed with their
respective standards, a no-template control, and a control excluding RT. Samples were run
on the Rotor-Gene 6000 (Corbett Life Sciences; Sydney, NSW, Australia) with the
following amplification conditions: 95°C for 5 minutes, denaturation for 10 seconds at
95°C, 10 seconds at 60°C to anneal primers, and a 20 second extension at 72°C (45 cycles).

2.11. Statistical Analyses
Data were analyzed using the unpaired t-test or the one-way analysis of variance (ANOVA)
with Tukey’s post-hoc test, as stated in the figure legends. A p value less than 0.05 as
determined by Prism software (GraphPad Software; La Jolla, CA, USA) was classified as
statistically significant.
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3.1. Confirmation of the S. pyogenes ΔFCT deletion mutant
Using the methods described in section 2.3.11, a clean deletion of the FCT region was
produced in the S. pyogenes strain MGAS8232 and confirmed by DNA sequencing. The
deletion was also verified by PCR using integration primers that flanked the excised region
(Figure 4A). A series of in vitro assays were then performed to validate this mutant and
ensure no pleiotropic effects occurred due to a theoretical secondary mutation that could
have occurred during the mutagenesis procedure. Using a cell surface extract and a TCA
precipitation to visualize the expression of cell surface-linked and secreted proteins,
respectively, we were able to verify that the ΔFCT mutant retains a similar protein
expression profile to the wildtype strain (Figure 4B, Figure 4C). As discussed earlier, the
superantigen SpeA is necessary to instigate an acute infection in our murine
nasopharyngeal model, and thus it was necessary to confirm that production of this toxin
was unchanged by the molecular cloning process. The TCA precipitations that were
previously performed were used as samples to generate an α-SpeA Western Blot. From this
process, we determined that there was no obvious difference in SpeA production in the
ΔFCT mutant (Figure 4D). Additionally, the wildtype strain and ΔFCT mutant were grown
for 20 hours to generate comparative growth curves. Since the two strains did not exhibit
differential growth, we were able to ensure that removal of the FCT region did not lead to
any discernable growth defects in THY broth (Figure 4E).

3.2. S. pyogenes FCT region genes mediate adhesion to collagen
type IV and fibronectin
Since several genes encoded within the FCT region have been implicated in adhesion, we
first sought to evaluate the adhesion capabilities of the ΔFCT mutant compared to the
wildtype strain. It has been well-documented that collagen type IV and fibronectin are
significant constituents of the nasopharyngeal ECM, and that the ability for bacteria to
adhere to them may contribute to streptococcal infection (99, 141–144). In particular,
collagen type IV is the most abundant ECM protein that underlays epithelial cells, and
although fibronectin is a minor component of the basement membrane, it is constantly
being secreted in order to mediate adhesion and migration of host cells (145, 146). In order
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Figure 4. Confirmation of the ∆FCT mutant and subsequent in vitro analyses.
(A) Integration primers flanking the FCT region were amplified using PCR followed by
DNA gel electrophoresis to confirm that the FCT region was deleted from the genome. In
vitro analyses were used to assess (B) surface protein expression by cell surface extract,
(C) secreted protein expression by trichloroacetic acid preparation, and (D) SpeA
superantigen expression by Western Blot (purified SpeA and SpeC were used as positive
and negative controls, respectively). (E) An automated BioScreen protocol was used to
generate growth curves for the wildtype MGAS8232 and ∆FCT mutant strains to ensure
that the ΔFCT mutant did not present any in vitro growth defects.
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to examine the adhesion properties of the wildtype and ΔFCT strains, a bacterial adhesion
assay was performed in which the bacteria were incubated with collagen type IV or
fibronectin before being stained by crystal violet. We discovered that wildtype MGAS8232
was entirely reliant on the presence of the FCT region in order to bind collagen type IV,
whereas binding to fibronectin was only partially reduced in the ΔFCT mutant (Figure 5A,
Figure 5B). These results demonstrate that under normal in vitro growth conditions, S.
pyogenes can produce functional FCT region-encoded proteins, most likely Cpa and PrtF2,
suggesting that they may be fundamental to the bacteria’s natural life cycle.

3.3

The FCT region genes do not mediate adhesion to human
pharyngeal cells by S. pyogenes

A vital step in the life cycle of S. pyogenes is its prompt adherence to a susceptible human
host; S. pyogenes can accomplish this task by utilizing numerous adhesion molecules. To
examine the adherence capabilities of S. pyogenes to relevant human tissue, the pharyngeal
cell line Detroit-562 was chosen due to its similarity of surface molecules with nontransformed pharyngeal cells, as well as its ability to induce certain superantigens and
DNAses that S. pyogenes cultured on its own is unable to express (147–149). In short,
wildtype MGAS8232 and the ΔFCT mutant were incubated over a confluent monolayer of
Detroit-562 cells, and after the non-adherent bacterial cells were washed away, the
remainder were plated for bacterial enumeration. We detected no differences in the binding
capabilities to Detroit-562 cells between the wildtype and ΔFCT strains (Figure 6). These
results indicate that the genes encoded within the FCT region are not essential for
adherence to these pharyngeal cells. It should be noted, however, that the natural
environment of S. pyogenes consists of more than one cell type, and adherence to the host
is a multifactorial event that needs to be explored further.

3.4

S. pyogenes invasion of human pharyngeal cells is
dependent on FCT region genes

In addition to adherence, FCT region genes are heavily implicated in the ability of S.
pyogenes to invade into host cells (101, 150, 151). Compared to other FBPs, PrtF2 (which
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Figure 5: The FCT region facilitates adhesion to collagen type IV and fibronectin.
Wells were coated with 1µg of human (A) collagen type IV, or (B) fibronectin, before
incubation with ~ 1 × 107 S. pyogenes CFUs at 37°C. Non-adherent cells were washed off
and the remaining cells were stained with 0.5% crystal violet before colorimetric analysis.
Bars represent the mean ± SEM; unpaired t-test was used to determine statistical
significance (***p<0.001, ****p<0.0001).
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Figure 6. The FCT region does not influence adhesion to Detroit-562 cells.
A confluent monolayer of the human pharyngeal cell line Detroit-562 was grown before
incubation with S. pyogenes (MOI of 100) at 37°C in 5% CO2 for 2.5 hours. The nonadherent bacterial cells were then washed away before disrupting the monolayer and
plating the suspension for bacterial enumeration. Each data point represents one in vitro
biological replicate. Error bars represent the mean ± SEM; statistical differences were
evaluated using the unpaired t-test, (p>0.05).
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is encoded by MGAS8232) is more commonly associated with severe S. pyogenes infection
and is more likely to correlate with invasive disease (101, 143, 152, 153). As such, we
wanted to characterize the natural invasive proficiency of our wildtype strain and elucidate
whether the ΔFCT mutant retained the same invasion potential. To test this query, we
utilized Detroit-562 cells in a similar fashion to our adhesion assay, but performed a
gentamycin protection assay to eliminate extracellular S. pyogenes prior to enumeration.
Strikingly, we discovered that removal of the FCT region completely eliminated the ability
to invade these pharyngeal cells (Figure 7). This assay provides compelling evidence to
reinforce the idea that the FCT region plays a significant role during host-cell invasion.

3.5

S. pyogenes expresses cpa, but neither tee18.1 nor prtF2 in
vivo

Within the biological context of nasopharyngeal infection, S. pyogenes must be able to
adhere to the nasopharynx and persist at the site of infection while withstanding an
inundation of mucociliary defenses. Success during this stage can be ascribed in part to the
repertoire of virulence factors and adhesion molecules. Therefore, we wanted to establish
the in vitro and in vivo expression profiles of the adherence-implicated genes encoded
within the FCT region of MGAS8232; this included: the major pilus subunit, tee18.1, the
collagen-binding protein, cpa, and the FBP, prtF2 (Figure 1).

In order to determine the expression of these genes in vitro, RNA was isolated from cultures
of S. pyogenes that were grown to early and late exponential phase. We then used qRTPCR to measure the transcripts of these genes and normalized their concentration to the
internal housekeeping gene, gyrA. We observed that cpa, tee18.1, and prtF2 were all being
transcribed at both early and late exponential phase, with cpa being transcribed at levels
higher than tee18.1 and prtF2 (Figure 8). Although not statistically significant, our data
depicts a slight trend for higher transcription levels for all FCT region genes during late
exponential phase, suggesting the possibility of temporal regulation for these genes. With
regards to in vivo expression, mice were infected for 48 hours with wildtype MGAS8232
and RNA was subsequently isolated from the cNTs before qRT-PCR analysis.
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Figure 7. The FCT region is necessary for invasion into Detroit-562 cells.
A confluent monolayer of the human pharyngeal cell line Detroit-562 was grown before
incubation with S. pyogenes (MOI of 100) at 37°C in 5% CO2 for 2.5 hours followed by 1
hour in

media supplemented with

100µg mL-1

of gentamycin. The non-

adherent/internalized bacterial cells were then washed away before disrupting the
monolayer and plating the suspension for bacterial enumeration. Each point represents an
in vitro biological replicate. Error bars represent the mean ± SEM; statistical differences
were evaluated using the unpaired t-test, (****p<0.0001).
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Figure 8. S. pyogenes transcribes FCT region genes in vitro.
mRNA was isolated from wildtype S. pyogenes MGAS8232 that was grown to early (OD600
~0.2) and late (OD600 ~0.8) exponential phase. Transcription levels were quantified using
qRT-PCR and normalized to the internal housekeeping gene gyrA (represented by the
dotted line at y = 1). Bars represent the mean ± SEM (n = 4 per growth phase analyzed
using duplicate values).
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In addition to measuring the absolute concentration of these gene transcripts, we also used
the 2-ΔΔCt method to compare the expression of these genes in wildtype-infected mice to
their in vitro expression (154). Moreover, we infected mice with the ΔFCT mutant and ran
qRT-PCR using RNA that was isolated from the extracted cNTS, which resulted in the
readouts for all genes below the limit of detection (Appendix II). Using mice that were
infected for 48 hours with wildtype MGAS8232, we observed that cpa transcripts were
produced at levels significantly higher than tee18.1 and prtF2 transcripts (Figure 9A).
Surprisingly, cpa transcripts in vivo were expressed in quantities comparable to in vitro
samples, whereas tee18.1 and prtF2 transcription was considerably downregulated in vivo
(Figure 9B). In fact, tee18.1 and prtF2 transcripts were identified at levels similar to what
was found in mice infected with the ΔFCT mutant, that is to say, transcription was
essentially undetectable (Figure 9A, Appendix II). These results suggest two possibilities:
(1) the pilus and/or PrtF2 are not expressed throughout the course of acute pharyngeal
infection, or (2) these proteins are regulated in a manner such that they are not detected 48
hours post-inoculation. To investigate the second possibility that either tee18.1 and/or
prtF2 would be transcribed during an earlier timepoint of infection, mice were again
inoculated with wildtype MGAS8232, but cNTs were harvested for RNA extraction after
24 hours. Similar to the 48 hour infection, cpa transcripts were detected at concentrations
several thousand fold higher than tee18.1 and prtF2 transcripts (Figure 10A). Remarkably,
transcription of cpa was greatly upregulated during a 24 hour infection compared to in vitro
samples, and was approximately 36 times greater at this shorter timepoint compared to 48
hours into infection (Figure 10A, Figure 10B, Appendix III). From this finding, we can
insinuate that cpa is expressed during the earlier stages of nasopharyngeal infection,
presumably to mediate adhesion to host tissue, and is subsequently downregulated as
infection progresses. With regards to tee18.1 and prtF2, transcription was again
exceedingly low and markedly downregulated compared to in vitro expression, indicating
that the major pilus subunit and FBP were not expressed at this timepoint either (Figure
10A, Figure 10B). These data suggest that the expression of certain FCT region
constituents are regulated in a manner that differs during in vitro expression compared to
an in vivo acute nasopharyngeal infection.
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Figure 9. Expression of FCT region genes during a 48 hour murine nasopharyngeal
infection.
Transgenic mice expressing HLA-DR4/DQ8 were inoculated with 1×108 CFUs of wildtype
S. pyogenes MGAS8232 and sacrificed 48 hours later. Their cNTs were then harvested and
processed for RNA extraction. qRT-PCR was used to measure the mRNA transcription
levels of cpa, tee18.1, and prtF2 and were then normalized to the housekeeping gene gyrA.
Data are presented as (A) the concentration of mRNA transcripts (gyrA denoted by the
dotted line at y = 1); and (B) the average fold change difference of gene transcription in
wildtype-infected mice (n = 5) relative to in vitro cultures [n = 4 for both early (OD600
~0.2) and late (OD600 ~0.8) exponential growth phases]. Bars represent the mean ± SEM;
1-way ANOVA with Tukey’s post-hoc test was used to determine statistical significance
(***p<0.001).
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Figure 10. Expression of FCT region genes during a 24 hour murine nasopharyngeal
infection.
Transgenic mice expressing HLA-DR4/DQ8 were inoculated with 1×108 CFUs of wildtype
S. pyogenes MGAS8232 and sacrificed 24 hours later. Their cNTs were then harvested and
processed for RNA extraction. qRT-PCR was used to measure the mRNA transcription
levels of cpa, tee18.1, and prtF2 and were then normalized to the housekeeping gene gyrA.
Data are presented as (A) the concentration of mRNA transcripts (gyrA denoted by the
dotted line at y = 1); and (B) the average fold change difference of gene transcription in
wildtype-infected mice (n = 4) relative to in vitro cultures [n = 4 for both early (OD600
~0.2) and late (OD600 ~0.8) exponential growth phases]. Bars represent the mean ± SEM;
1-way ANOVA with Tukey’s post-hoc test was used to determine statistical significance
(***p<0.001).
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3.6

FCT region genes are not required for infection by S.
pyogenes in the murine nasopharynx

Ultimately, we sought to ascertain whether deletion of the FCT region would have any
bearing on the ability of S. pyogenes to stimulate an acute nasopharyngeal infection in
mice. Using the previously described murine infection model, cNTs were harvested 48
hours post-inoculation and processed for bacterial enumeration. We discovered that
transgenic mice expressing the HLA-MHC II molecule (alleles DQ8 and DR4/DQ8) were
infected by the wildtype strain and ΔFCT mutant at comparable magnitudes (Figure 11).
Taken together, these experiments provide convincing evidence that the FCT region does
not play an essential role during acute nasopharyngeal infection by S. pyogenes
MGAS8232.
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Figure 11. Acute nasopharyngeal infection of transgenic mice by S. pyogenes.
Transgenic mice expressing (A) HLA-DQ8, or (B) HLA-DR4/DQ8 were infected with
~1×108 wildtype S. pyogenes MGAS8232 or the ΔFCT mutant for 48 hours before
sacrifice. Their cNTs were then harvested and processed for bacterial enumeration. Each
data point represents an individual mouse and statistical differences were evaluated by the
unpaired t-test (p>0.05).
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4. Discussion
The evolution of S. pyogenes has resulted in a bacterium that is exquisitely adapted to its
human host. Its capacity to establish infection, colonize, and persist in the human
population can be attributed to its abundance of virulence factors. These molecular
elements, and the precise regulation of them, permit S. pyogenes to successfully overcome
environmental and metabolic challenges, adhere to host tissue, survive intracellularly, and
circumvent the host immune system. The FCT region is a genetically diverse genomic
locus that encodes such elements, many of which have been implicated in the life cycle of
S. pyogenes by directly mediating adhesion, invasion, and regulation of locus-specific and
chromosomally-distant virulence factors.

In this study, I intended to examine the FCT region of S. pyogenes MGAS8232 in order to
characterize its properties and functions and how it pertains to pharyngeal infection. I
accomplished this aim by generating a mutant with the entire FCT region deleted, rather
than single mutants of the investigated genes. However, this presented a challenge to
determine which gene(s) were responsible for which results. Therefore, it became
necessary to formulate interpretations of our results by carefully analyzing the data with
respect to the available literature on how these genes act individually, as well as how they
are predicted to behave collectively.

Our first objective was to confirm that S. pyogenes possessed the capacity to bind ECM
proteins that are found in the nasopharynx (146, 155). Remarkably, we discovered that the
ΔFCT mutant had completely lost its ability to bind collagen type IV and had significantly
reduced adherence to fibronectin (Figure 5A, Figure 5B). The most likely protein
candidates responsible for this loss of phenotype are Cpa and PrtF2 as they are the only
FCT region constituents known to directly bind ECM proteins (45, 156). With regards to
collagen type IV, both Cpa and PrtF2 contain collagen-binding domains; these domains in
PrtF2, however, are secluded from the extracellular milieu and are predicted to have a role
in conferring structural stability against extremely high temperatures and low pH (109,
157). For this reason, we infer that Cpa is likely mediating adhesion to collagen type IV.
Intriguingly, many strains associated with pharyngitis and ARF exhibit weak binding to
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collagen type IV, further supporting the notion that a significant portion of strainspecificity originates from within the FCT region. (49, 99). PrtF2 has been described as an
important adhesin during infection and colonization by S. pyogenes (106, 142). We
substantiated this claim by demonstrating a reduction in fibronectin-binding capacity by
MGAS8232 upon removal of the FCT region (Figure 5B). Although fibronectin-binding
decreased substantially, there still remained some residual binding capabilities. This
finding was logical, however, as analysis of the MGAS8232 genome illuminated the
presence of a putative FBP, spyM18_0997 (an FbpA-like protein), encoded outside of the
FCT region (135). Impressively, for strains that encode prtF2, it is typically considered a
major factor in determining the tropism and severity of infection for that specific strain,
and so, it is possible that in the absence of PrtF2, this putative FBP may be upregulated in
an attempt to rescue fibronectin-binding (101, 104, 145, 152, 158, 159). From a regulatory
perspective, it would be worthwhile to examine how S. pyogenes adapts to the loss of its
major FBP(s) both in vitro and throughout an in vivo infection model. Additional future
endeavours can explore the binding capabilities to different collagen types, as well as other
ECM proteins, such as laminin, which is a major constituent of the basement membrane
(160).

It has previously been demonstrated in a number of serotypes that the FCT region is crucial
for binding eukaryotic cells that are associated with different sites of infection (89, 90,
161). We therefore sought to demonstrate this capacity in our strain against the human
pharyngeal cell line Detroit-562 and observed that the absence of the FCT region did not
impede the ability of S. pyogenes to adhere to these cells (Figure 6). This result conflicts
with previous reports that implicate the FCT region genes in adherence to relevant human
tissue (57, 89). It stands to reason that MGAS8232 may not be adept at directly binding
human cells without the scaffold of ECM proteins. If this is the case, adhesion in the
nasopharynx may transpire through an uncharacterized avenue. That is, it may be necessary
for S. pyogenes to utilize a mechanism that disrupts the host epithelial barrier to expose the
underlying ECM to permit adhesion. This is likely a dynamic process that features several
virulence factors such as the hyaluronic acid capsule, which is able to alter cytoskeletal
arrangements resulting in an opening of intercellular junctions; the protease SpeB, which
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can directly degrade components of intercellular junctions; and/or streptolysin S, which
may activate the host protein calpain inducing disruption of cell-to-cell linkages thereby
allowing S. pyogenes to travel across the epithelial barrier and gain access to ECM proteins
(67, 162–164). Conversely, MGAS8232 may indeed mediate adhesion to Detroit-562 cells
via its FCT region genes, but the presence of other adhesion molecules, such as the
hyaluronic acid capsule, may have rescued the adherence phenotype that we theoretically
expected to decrease in the ΔFCT mutant, thereby confounding our results.

Although our adhesion assay did not demonstrate any loss of binding capabilities to
Detroit-562 cells, we speculated whether deletion of the FCT region would impact invasion
of S. pyogenes. We identified an extraordinary phenotype in which invasion by the ΔFCT
mutant is completely suppressed (Figure 7). This validates previous studies that have
implicated the FCT region, and PrtF2 specifically, in invasion (101, 104, 143, 165, 166).
Binding interactions between fibronectin and PrtF2 (and homologous FBPs) have been
well characterized, and involve the FBP forming an energetically favourable β-zipper with
fibronectin (105, 167, 168). Subsequently, S. pyogenes FBP can interact with a fragment
of fibronectin that is hypothesized to stimulate α5β1 integrin clustering to promote invasion
into the host cell (77, 109, 168). Moreover, epithelial cells, such as Detroit-562 cells, have
been shown to secrete fibronectin to its apical surface, and together with saliva-derived
fibronectin, S. pyogenes has ample opportunities to interact with fibronectin and initiate
invasion (169–172). Importantly, PrtF2-mediated invasion is likely a major contributor to
the intracellular life cycle; in an epidemiological study of S. pyogenes isolated from
children, 80% of asymptomatic throat carriers were found to be prtF2+ (173). This
hypothesis is substantiated by data that identified concurrent presence of prtF1 and prtF2
were associated with high erythromycin resistance, suggesting that S. pyogenes may
internalize into host cells using these FBPs as a means to evade immune detection and
antibiotic treatment (159). Coupled with the lack of altered adhesion efficiency from
Figure 6, our results demonstrate how FCT region-mediated adhesion and invasion are not
necessarily linked in S. pyogenes as commonly described (101, 145, 174).
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In this study, we discovered that during an in vivo murine nasopharyngeal infection, cpa
was unequivocally being expressed both 24, and 48 hours post-inoculation, and that
transcription of cpa was greater at the 24-hour timepoint (Figure 9A, Figure 10A).
Accordingly, we can infer that Cpa is critical to the initial attachment of S. pyogenes to a
susceptible host. Transcripts for tee18.1, however, were essentially undetectable (Figure
9A, Figure 10A). This result was curious given that Cpa is often, albeit not always,
predicted to be the pilus tip adhesin and is typically situated atop the pilus structure (47,
97, 98, 100). Interestingly enough, in MGAS8232 cpa contains a VVPTG motif, which is
one of the sequences recognized by srtC2, a specialized sortase encoded within the FCT
region (95, 135). srtC2 is unique in that its catalytic domain is architecturally flexible
thereby allowing it to interact with more variable substrates (96). This feature was likely a
consequence of evolution to physically accommodate the strain- and serotype-specific
sequences of the major pilus subunit and its ancillary protein(s). Thus, the possibility exists
that Cpa is linked directly to the cell wall via an FCT region dedicated sortase. This would
suggest that for some strains, it would not benefit S. pyogenes to consume energy to
produce pili if the associated adhesin is able to be presented in a more efficient manner.

Nevertheless, the lack of tee18.1 transcript needs to be further investigated since pilus
assembly and presentation on S. pyogenes M18 serotypes is not well understood (49, 133,
175, 176). This finding entails the possibility that some strains of S. pyogenes, such as the
one used in this study, do not naturally express the pilus during its infectious life cycle, yet
still transcribe the tee gene in vitro (Figure 8, Figure 9B, Figure 10B). A previous analysis
of M3 serotypes, which share the FCT-3 variant that MGAS8232 has, determined that the
pilus assembly mechanism was effectively nonexistent, and that presentation of the pilus
on the bacterial cell was only accomplished by artificially upregulating the genes (133).
We can therefore posit that the nature of the pilus may have resulted in some strains, such
as MGAS8232, ablating expression of the pilus in vivo. This phenomenon could have been
caused by the presence of other virulence factors that are sufficient at mediating adhesion,
or perhaps as an approach to avoid immune detection. Hence, this finding further illustrates
that selective regulation and production of the pilus is a critical factor that is dependant on
strain-specific needs in vivo during the infectious life cycle. For instance, clinical M3
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isolates are regulated in a manner that yields low or negligible levels of pili, which may
reduce the adherence of the bacteria from host tissue and allow survival, replication, and
dissemination in human blood (133). Disruption of the pilus assembly mechanism in an
M1 strain drives the bacteria toward a virulent phenotype, implying that the pilus is active
in maintaining colonization rather than promoting disease (98). This concept is further
supported by a study that demonstrated how a marked increase in pilus production by an
invasive M3 strain resulted in decreased virulence and increased adherence to human
epithelial cells (177). The constitutive expression of pili, however, may be detrimental to
S. pyogenes colonization. M1 serotypes require their pili to establish epithelial infection
and colonization, yet due to the immunogenicity of the major pilus subunit, superfluous
expression of their pili leads to recognition by phagocytes prompting a neutrophil-driven
immune response that elevates S. pyogenes killing through neutrophil extracellular
entrapment (178). Concerning MGAS8232, immunogold labeling or Western blot using
antibodies raised against the major pilus subunit would provide definitive evidence
regarding the expression of the pilus both in vitro and in vivo.

With regards to the expression of prtF2, we discovered that no transcripts were being
synthesized in vivo. Dissimilar to the situation concerning tee18.1, we are confident that
MGAS8232 is able to transcribe and translate a functional PrtF2 protein, given that prtF2
transcripts were produced in measurable quantities in vitro, and that our fibronectinbinding assay clearly demonstrated that excision of the FCT region attenuates binding to
fibronectin (Figure 5B, Figure 8). A plausible explanation for not detecting expression of
prtF2 in vivo revolves around its regulation. Although PrtF2 is heavily implicated in direct
adhesion to fibronectin, characterization of this protein has predominantly described its
primary function as facilitating invasion into mucosal and skin-associated epithelial cells
(101, 102, 152, 159, 174). Therefore, S. pyogenes must produce maximal concentrations
of this protein when invasion is optimal, which occurs after the bacteria have adhered
successfully to their site of infection. Transcription analysis of prtF2 has shown that the
gene is upregulated linearly near the end of exponential phase, and rapidly declines in the
early stationary growth phase (101). In relation to our murine nasopharyngeal infection,
the precise interval when prtF2 is being transcribed is currently unknown and may occur
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between 24 and 48 hours. To clarify this scenario, a more thorough in vivo time course
should be performed, one that closely assesses the expression of FCT region genes,
including transcription of the FBP-associated regulator msmR (137). Alternatively, cNT
homogenates can be processed to extract cell surface-linked proteins, including PrtF2, from
the bacteria; afterwards, the suspension can be used for immunoblotting against
biotinylated fibronectin in order to visualize the presence of translated PrtF2 during an in
vivo infection model (179).

Collectively, our in vivo qRT-PCR analysis reveals that Cpa might be integral during the
early stages of pharyngeal infection, whereas the expression status of the pilus and PrtF2
is still unclear. The detection of tee18.1 and prtF2 transcripts in vitro, however, imply that
these genes may be temporally or spatially regulated. Moving forward, we resolved to
measure the bacterial burden of S. pyogenes during a murine nasopharyngeal infection and
anticipated that the ΔFCT mutant would exhibit an attenuated infection phenotype. Using
this model, we did not observe lower bacterial counts following inoculation with the ΔFCT
mutant, clearly indicating that the FCT region is not essential for MGAS8232 pharyngeal
infection (Figure 11).

The genetic diversity of the FCT region likely helps aid S. pyogenes in its quest to infect
and colonize humans successfully. In spite of the genomic diversity, however, the pilus
may hold the potential for therapeutic developments. Naturally, since pili are relatively
exposed on the bacterial surface, various pilus components are being examined as potential
vaccine candidates, the most prominent of which being the major pilus subunit due to its
strong immunogenicity (180). This area of research is still quite new and is complicated by
the fact that the tee gene has massive diversity between S. pyogenes strains. Still, the
protection conferred by the major pilus subunit is comparable to the protection conferred
by the M protein in mice, yet there is significantly more genetic variation within the emm
gene compared to the tee gene (47). One vaccination-based study used Lactococcus lactis
recombinantly expressing S. pyogenes pili as a vector in order to stimulate a protective
response against S. pyogenes bacterial challenge (176). Specifically, antibodies raised
against MGAS8232 pili that were expressed on L. lactis inhibited adhesion by S. pyogenes
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to skin in rabbits, while mice subjected to intranasal immunization were protected against
nasopharyngeal infection (176). Even accounting for the diversity in tee, estimates suggest
that a pilus-based vaccine that incorporates protective epitopes from twelve of the most
common major pilus subunits would confer protection against >90% of S. pyogenes strains
in the United States of America and the European Union (76).

S. pyogenes remains a significant burden on human health, and developing a thorough
understanding of its asymptomatic and pathogenic life cycle is vital to prevent and treat
complications of infection. The FCT region is a highly recombinatorial locus within the
genome of all S. pyogenes strains, and encodes numerous genes that may contribute to
tissue tropism as well as the propensity to cause invasive disease. In this study, we
characterized the binding capacity of S. pyogenes to collagen type IV and fibronectin and
determined that the FCT region is indeed pertinent to binding these ECM proteins. We
additionally characterized the adherence and invasion capabilities to pharyngeal tissue and
have demonstrated that adhesion is not influenced by the FCT region, whereas invasion is
greatly dependent on its presence. Finally, our work suggests that although the FCT region
is not required to establish nasopharyngeal infection in mice, thereby nullifying our
hypothesis, we provide transcriptional evidence that cpa may have a minor role during the
early stages of pharyngeal infection. To conclude, further exploration of this diverse
genomic locus holds the potential to comprehensively evaluate the life cycle of S.
pyogenes, which in turn can provide insight on how to combat this globally-prevalent
pathogen.
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Appendices

Appendix I. Animal ethics approval certification.
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Appendix II. Detection of FCT region genes in mice infected with the MGAS8232
ΔFCT mutant, a representation of zero/undetectable transcription.
Transgenic mice (n = 4) expressing HLA-DR4/DQ8 were inoculated with 1×108 CFUs of
the S. pyogenes MGAS8232 ΔFCT mutant and sacrificed 48 hours later. Their complete
nasal turbinates were then harvested and processed for RNA extraction. qRT-PCR was then
used to measure the mRNA transcription levels of cpa, tee18.1, and prtF2 in these mice
normalized to the housekeeping gene gyrA. Bars represent the mean ± SEM of 4 mice
analyzed using triplicate values.
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Appendix III. Expression of cpa during murine nasopharyngeal infections 24 and 48
hours post-inoculation.
Transgenic mice expressing HLA-DR4/DQ8 were inoculated with 1×108 CFUs of wildtype
S. pyogenes MGAS8232 and sacrificed 24 (n = 4) or 48 (n = 5) hours later. Their cNTs
were harvested and processed for RNA extraction. qRT-PCR was then used to measure the
mRNA transcription levels of cpa in these mice normalized to the housekeeping gene gyrA.
Bars represent the mean ± SEM; statistical differences were evaluated using the unpaired
t-test, (**p<0.01).
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